News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,394 Results
Type
Article (3906)
Company Profile (16)
Press Release (67472)
Section
Business (21158)
Career Advice (957)
Deals (3811)
Drug Delivery (10)
Drug Development (8094)
Employer Resources (44)
FDA (1716)
Job Trends (1995)
News (35909)
Policy (3451)
Tag
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2026 Pharm Country Premier (1)
Academia (478)
Accelerated approval (1)
Adcomms (1)
Allergies (5)
Alliances (7352)
ALS (4)
Alzheimer's disease (160)
Antibody-drug conjugate (ADC) (8)
Approvals (1712)
Artificial intelligence (53)
Autoimmune disease (1)
Automation (2)
Bankruptcy (18)
Best Places to Work (1789)
BIOSECURE Act (2)
Biosimilars (7)
Biotechnology (14)
Bladder cancer (13)
Brain cancer (4)
Breast cancer (23)
Cancer (218)
Cardiovascular disease (16)
Career advice (760)
Career pathing (13)
CAR-T (17)
Cell therapy (44)
Cervical cancer (1)
Clinical research (6345)
Collaboration (145)
Compensation (18)
Complete response letters (3)
COVID-19 (352)
CRISPR (8)
C-suite (27)
Cystic fibrosis (14)
Data (221)
Depression (3)
Diabetes (18)
Diagnostics (956)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (17)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (6)
Earnings (6731)
Editorial (1)
Employer branding (8)
Employer resources (36)
Events (8887)
Executive appointments (72)
FDA (1842)
Featured Employer (5)
Friedreich's ataxia (1)
Funding (94)
Gene editing (16)
Generative AI (7)
Gene therapy (35)
GLP-1 (55)
Government (530)
Guidances (6)
Healthcare (2325)
Huntington's disease (2)
IgA nephropathy (5)
Immunology and inflammation (13)
Indications (2)
Infectious disease (371)
Inflammatory bowel disease (16)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (12)
Interviews (184)
IPO (2011)
IRA (4)
Job creations (279)
Job search strategy (603)
Labor market (10)
Layoffs (40)
Leadership (4)
Legal (576)
Liver cancer (5)
Lung cancer (27)
Lymphoma (19)
Machine learning (2)
Management (13)
Manufacturing (32)
MASH (5)
Medical device (1256)
Medtech (1256)
Mergers & acquisitions (1865)
Metabolic disorders (47)
Multiple sclerosis (9)
NASH (2)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (205)
NextGen: Class of 2025 (728)
Non-profit (539)
Northern California (278)
Now hiring (3)
Obesity (21)
Opinion (45)
Ovarian cancer (3)
Pain (8)
Pancreatic cancer (7)
Parkinson's disease (9)
Partnered (3)
Patents (31)
Patient recruitment (9)
Peanut (4)
People (5853)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase I (1898)
Phase II (2761)
Phase III (2202)
Pipeline (127)
Policy (16)
Postmarket research (288)
Preclinical (968)
Press Release (9)
Prostate cancer (8)
Psychedelics (1)
Radiopharmaceuticals (22)
Rare diseases (46)
Real estate (538)
Recruiting (22)
Regulatory (2553)
Reports (7)
Research institute (358)
Resumes & cover letters (246)
RNA editing (1)
RSV (5)
Schizophrenia (5)
Series A (14)
Series B (10)
Service/supplier (1)
Sickle cell disease (5)
Southern California (274)
Special edition (4)
Spinal muscular atrophy (15)
Sponsored (6)
Startups (487)
Supply chain (4)
Tariffs (6)
The Weekly (2)
United States (2102)
Vaccines (84)
Venture capitalists (3)
Weight loss (13)
Women's health (3)
Worklife (4)
Date
Today (19)
Last 7 days (88)
Last 30 days (298)
Last 365 days (3439)
2025 (1073)
2024 (3748)
2023 (4631)
2022 (5930)
2021 (6694)
2020 (6594)
2019 (5790)
2018 (4326)
2017 (3551)
2016 (3522)
2015 (3635)
2014 (2511)
2013 (2079)
2012 (2287)
2011 (2613)
2010 (2310)
Location
Africa (130)
Alabama (2)
Alaska (4)
Arizona (13)
Arkansas (4)
Asia (3959)
Australia (827)
California (663)
Canada (281)
China (37)
Colorado (13)
Connecticut (40)
Delaware (12)
Europe (11315)
Florida (64)
Georgia (18)
Idaho (5)
Illinois (44)
India (5)
Indiana (14)
Iowa (2)
Japan (18)
Kansas (6)
Louisiana (1)
Maine (2)
Maryland (75)
Massachusetts (426)
Michigan (6)
Minnesota (25)
Missouri (9)
Montana (5)
Nebraska (3)
Nevada (5)
New Hampshire (4)
New Jersey (173)
New Mexico (2)
New York (182)
North Carolina (62)
North Dakota (1)
Northern California (278)
Ohio (30)
Oklahoma (1)
Oregon (5)
Pennsylvania (83)
Rhode Island (4)
South America (154)
South Carolina (3)
Southern California (274)
Tennessee (5)
Texas (45)
Utah (7)
Virginia (21)
Washington D.C. (4)
Washington State (82)
West Virginia (1)
Wisconsin (7)
71,394 Results for "applied nanoscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Applied Nanoscience Inc. Commissions U.S.-based Pilot Plant and Unveils Strategic IP Sale Process
Applied Nanoscience Inc. disclosed that a newly constructed pilot plant has been commissioned to ensure reliable production scale-up of the company’s groundbreaking NanoFense technology.
January 24, 2024
·
2 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
April 14, 2025
·
10 min read
Executive Appointments
After Month of Bad News, Applied Shuffles Leadership, Lays Out Uncertain Path for Rare Disease Drug
Following a 90% drop in share price due to an FDA rejection and a warning letter over Applied Therapeutics’ conduct during a clinical trial, the biotech’s CEO has stepped aside.
December 23, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
Business
Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World
Ceres Nanosciences and Ginkgo Bioworks announced that they are partnering to bring pathogen monitoring capabilities to laboratories around the world.
September 12, 2023
·
6 min read
Press Releases
Applied StemCell Announces Drug Master File Submission to the US FDA for their GMP-Grade iPSC Cell Line
April 14, 2025
·
2 min read
Press Releases
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
March 19, 2025
·
4 min read
Press Releases
Applied DNA’s LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
April 22, 2025
·
4 min read
1 of 7,140
Next
